Medical Device Network

Anaconda Biomed raises $56m for catheter portfolio’s advance

Anaconda Biomed has raised $56m to advance the clinical development of its mechanical thrombectomy catheter portfolio and complete the pivotal investigational device exemption (ID ...
Medical Device Network

Brainomix’s e-Lung shows progression and treatment response in Phase III trial

Brainomix’s e-Lung was proven sensitive to the effects of antifibrotic treatment. Credit: Marko Aliaksandr / Shutterstock.com. Brainomix has debuted data from a Phase III progressive pulmonary ...
Medical Device Network

UKRI launches £80m ‘Dementia Challenge’ programme

In 2025, over 72,000 people across the UK died from dementia, including Alzheimer’s, according to Alzheimer’s Research UK. Credit: SewCreamStudio / Shutterstock.com. UK Research and Innovation (UKRI) ...
Medical Device Network

Roche’s TIB MOLBIOL introduces in vitro newborn screening test kit

The kit is intended for academic and private hospital laboratories to support early detection and prompt medical intervention. Credit: New Africa / Shutterstock.com. Roche Diagnostics subsidiary TIB ...
Medical Device Network

Siemens Healthineers introduces Innovance D-Dimer 2.0 assay

The Innovance D-Dimer 2.0 assay forms part of the Siemens Healthineers thrombotic disorder range. Credit: Siemens Healthineers. Siemens Healthineers has introduced its Innovance D-Dimer 2.0 assay ...
Medical Device Network

Podcast: Continuous monitoring’s burgeoning role in metabolic health

BioLinq’s president and CTO, Jared Tangney, talks about the potential of continuous monitoring in the management of metabolic conditions such as diabetes and obesity. Credit: GlobalData. In recent ...
Medical Device Network

FDA clears Cepheid’s multiplex respiratory panel test

Xpert Respiratory Panel addresses diagnostic challenges associated with acute respiratory conditions. Credit: sasirin pamai/Shutterstock.com. The US Food and Drug Administration (FDA) has granted ...
Medical Device Network

Patients want flexible and involved cardiac care, but cost hurdles remain

Respondents were generally interested in at-home cardiac rehabilitation care, but they noted that cost and practicality were key barriers to uptake. Credit: Fagreia / Shutterstock.com. A new survey ...
Medical Device Network

Dexcom report paints mixed picture of CGM use by people with type 2 diabetes

Dexcom released its State of Type 2 report ahead of the 2026 EASD congress, taking place 28 September to 2 October in Milan, Italy. Credit: JHVEPhoto/Shutterstock.com Significant gaps remain in ...
Medical Device Network

FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics

Hyperglycaemia is common among ill newborns and premature infants and is associated with poor outcomes in this patient group. Credit: Yuriy K / Shutterstock.com. The US Food and Drug Administration ...
Medical Device Network

Aptar Pharma and Macquarie University partner on drug delivery project

Aptar Pharma is collaborating with Macquarie University in a partnership that will see the drug delivery specialist and Australian institution investigate formulation approaches designed to support ...